Novel therapeutic strategies for patients with NSCLC that do not respond to treatment with EGFR inhibitors-Reference-Cited by-同舟云学术

Novel therapeutic strategies for patients with NSCLC that do not respond to treatment with EGFR inhibitors

Published:2014-09 Issue:8 Volume:40 Page:990-1004
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Rolfo Christian,Giovannetti Elisa,Hong David S.,Bivona T.,Raez Luis E.,Bronte Giuseppe,Buffoni Lucio,Reguart Noemí,Santos Edgardo S.,Germonpre Paul,Taron Mìquel,Passiglia Francesco,Van Meerbeeck Jan P.,Russo Antonio,Peeters Marc,Gil-Bazo Ignacio,Pauwels Patrick,Rosell Rafael

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Reference156 articles.

1. Driver mutations and differential sensitivity to targeted therapies: a new approach to the treatment of lung adenocarcinoma;Bronte;Cancer Treat Rev,2010

2. Primary and acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer: an update;Ayoola;Cancer Invests,2012

3. Fukuoka M, Yano S, Giaccone G, Tamura T, Nakagawa K, Douillard JY, et al. Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected]. J Clin Oncol 2003; 21(12): 2237–46. [Epub 2003 May 14. Erratum in J Clin Oncol 2004; 22(23):4863].

4. Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non–small cell lung cancer: a randomized trial;Kris;JAMA,2003

5. Determinants of tumor response and survival with erlotinib in patients with non–small-cell lung cancer;Pérez-Soler;J Clin Oncol,2004

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticancer Evaluation of Novel Benzofuran–Indole Hybrids as Epidermal Growth Factor Receptor Inhibitors against Non-Small-Cell Lung Cancer Cells;Pharmaceuticals;2024-02-09

2. The cell line models to study tyrosine kinase inhibitors in non-small cell lung cancer with mutations in the epidermal growth factor receptor: A scoping review;Critical Reviews in Oncology/Hematology;2024-02

3. Characterization, Anti-lung Cancer Activity, and Cytotoxicity of Bio-synthesized Copper Nanoparticles by Thymus fedtschenkoi Leaf Extract;Journal of Cluster Science;2023-11-28

4. Liquid Biopsies in Lung Cancer;Cancers;2023-02-23

5. In Vitro Anticancer Activity of Novel Ciprofloxacin Mannich Base in Lung Adenocarcinoma and High-Grade Serous Ovarian Cancer Cell Lines via Attenuating MAPK Signaling Pathway;Molecules;2023-01-23